99 related articles for article (PubMed ID: 2938025)
1. Parkinson's disease: decreased density of 3H-imipramine and 3H-paroxetine binding sites in putamen.
Raisman R; Cash R; Agid Y
Neurology; 1986 Apr; 36(4):556-60. PubMed ID: 2938025
[TBL] [Abstract][Full Text] [Related]
2. Antidepressant binding sites in brain: autoradiographic comparison of [3H]paroxetine and [3H]imipramine localization and relationship to serotonin transporter.
Hrdina PD; Foy B; Hepner A; Summers RJ
J Pharmacol Exp Ther; 1990 Jan; 252(1):410-8. PubMed ID: 2137177
[TBL] [Abstract][Full Text] [Related]
3. High affinity binding of 3H-paroxetine and 3H-imipramine to rat neuronal membranes.
Mellerup ET; Plenge P
Psychopharmacology (Berl); 1986; 89(4):436-9. PubMed ID: 2944152
[TBL] [Abstract][Full Text] [Related]
4. High and low affinity [3H]imipramine binding sites in control and parkinsonian brains.
Cash R; Raisman R; Ploska A; Agid Y
Eur J Pharmacol; 1985 Oct; 117(1):71-80. PubMed ID: 3002804
[TBL] [Abstract][Full Text] [Related]
5. Autoradiography of antidepressant binding sites in the human brain: localization using [3H]imipramine and [3H]paroxetine.
Cortés R; Soriano E; Pazos A; Probst A; Palacios JM
Neuroscience; 1988 Nov; 27(2):473-96. PubMed ID: 2975361
[TBL] [Abstract][Full Text] [Related]
6. Regional distribution of the serotonin transport complex in human brain, identified with 3H-paroxetine, 3H-citalopram and 3H-imipramine.
Plenge P; Mellerup ET; Laursen H
Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(1):61-72. PubMed ID: 2137251
[TBL] [Abstract][Full Text] [Related]
7. Characterization of [3H]paroxetine binding in rat brain.
Marcusson JO; Bergström M; Eriksson K; Ross SB
J Neurochem; 1988 Jun; 50(6):1783-90. PubMed ID: 2967349
[TBL] [Abstract][Full Text] [Related]
8. Studies on the serotonin transporter in platelets.
Langer SZ; Galzin AM
Experientia; 1988 Feb; 44(2):127-30. PubMed ID: 2964377
[TBL] [Abstract][Full Text] [Related]
9. Comparison of [3H]paroxetine and [3H]cyanoimipramine for quantitative measurement of serotonin transporter sites in human brain.
Gurevich EV; Joyce JN
Neuropsychopharmacology; 1996 May; 14(5):309-23. PubMed ID: 8703300
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of MAO activity, 3H-imipramine binding, 3H-paroxetine binding and 3H-5-HT uptake by human cerebrospinal fluid.
Egashira T; Goto S; Murayama F; Yamanaka Y
J Neural Transm Suppl; 1990; 32():447-56. PubMed ID: 2150970
[TBL] [Abstract][Full Text] [Related]
11. [3H]paroxetine binding and serotonin content of rat and rabbit cortical areas, hippocampus, neostriatum, ventral mesencephalic tegmentum, and midbrain raphe nuclei region.
Dewar KM; Reader TA; Grondin L; Descarries L
Synapse; 1991 Sep; 9(1):14-26. PubMed ID: 1724575
[TBL] [Abstract][Full Text] [Related]
12. High affinity [3H]imipramine and [3H]paroxetine binding sites in suicide brains.
Rosel P; Arranz B; Vallejo J; Oros M; Menchón JM; Alvarez P; Navarro MA
J Neural Transm (Vienna); 1997; 104(8-9):921-9. PubMed ID: 9451724
[TBL] [Abstract][Full Text] [Related]
13. Affinity modulation of [3H]imipramine, [3H]paroxetine and [3H]citalopram binding to the 5-HT transporter from brain and platelets.
Plenge P; Mellerup ET; Laursen H
Eur J Pharmacol; 1991 Mar; 206(3):243-50. PubMed ID: 1830276
[TBL] [Abstract][Full Text] [Related]
14. Antidepressive drugs can change the affinity of [3H]imipramine and [3H]paroxetine binding to platelet and neuronal membranes.
Plenge P; Mellerup ET
Eur J Pharmacol; 1985 Dec; 119(1-2):1-8. PubMed ID: 2935414
[TBL] [Abstract][Full Text] [Related]
15. High affinity binding of [3H]paroxetine and [3H]imipramine to human platelet membranes.
Mellerup ET; Plenge P; Engelstoft M
Eur J Pharmacol; 1983 Dec; 96(3-4):303-9. PubMed ID: 6233162
[TBL] [Abstract][Full Text] [Related]
16. Platelet 3H-paroxetine binding to the serotonin transporter is insensitive to changes in central serotonergic innervation in the rat.
Moret C; Briley M
Psychiatry Res; 1991 Aug; 38(2):97-104. PubMed ID: 1836639
[TBL] [Abstract][Full Text] [Related]
17. Regional distribution of specific high affinity binding sites for 3H-imipramine and 3H-paroxetine in human brain.
Rosel P; Menchon JM; Oros M; Vallejo J; Cortadellas T; Arranz B; Alvarez P; Navarro MA
J Neural Transm (Vienna); 1997; 104(1):89-96. PubMed ID: 9085196
[TBL] [Abstract][Full Text] [Related]
18. [3H] imipramine binding in brain samples from depressed suicides and controls: 5-HT uptake sites compared with sites defined by desmethylimipramine.
Lawrence KM; Kanagasundaram M; Lowther S; Katona CL; Crompton MR; Horton RW
J Affect Disord; 1998 Jan; 47(1-3):105-12. PubMed ID: 9476750
[TBL] [Abstract][Full Text] [Related]
19. Pitfalls in demonstrating an endogenous ligand of imipramine recognition sites.
Lee CR; Galzin AM; Taranger MA; Langer SZ
Biochem Pharmacol; 1987 Mar; 36(6):945-9. PubMed ID: 3032200
[TBL] [Abstract][Full Text] [Related]
20. Evidence for the existence of serotonin uptake inhibitor-like substances in human cerebrospinal fluid.
Goto S; Egashira T; Yamanaka Y
Jpn J Pharmacol; 1991 Jul; 56(3):297-302. PubMed ID: 1832727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
